The Long Run with Luke Timmerman

Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

Mar 14, 2022
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Ray Stevens, Welcome to the Long Run
02:56 • 2min
3
What Was It Like Growing Up in Auburn, Main?
04:26 • 2min
4
Growing Up, What Do You Do for a Living?
06:04 • 2min
5
What Kind of Student Did You Be?
07:43 • 2min
6
University of Southern Maine
09:25 • 3min
7
How Did You Get Into Pharmacology?
12:24 • 3min
8
Aurkly, I'm a Chemist and I'd Like to Be an Independent Professor
15:34 • 3min
9
What Was So Difficult About GPC Rs?
18:25 • 3min
10
Do You Have Any Success With G Protin Coupled Receptors?
20:58 • 3min
11
Collaboration With Pete Scholtz Was Incredibly Productive
24:05 • 2min
12
What Kind of Skills Were You Surrounded by at Te Scrips?
26:05 • 2min
13
How Did You Become a Biotechnologist?
28:01 • 2min
14
What I Love About Starting Biote Companies
30:07 • 2min
15
The Long Run Podcast
31:52 • 2min
16
How Big of a Life Anger Was This for You as a Co-Founder?
33:45 • 3min
17
Is Small Molecule a Better Modality Than a Biologic?
36:46 • 2min
18
Drug Discovery Platform - What Are the Biggest Breakthroughs?
38:20 • 2min
19
Receptos Salgin's Not Going to Do Anything With This.
40:39 • 2min
20
How Did You See the Potential in China?
43:04 • 4min
21
You're No Longer a Professor at Us C
47:30 • 2min
22
How Much of the Language Do You Speak?
49:15 • 3min
23
How to Build Trust in a Bilateral Company?
52:19 • 4min
24
How to Get the Most Out of Your Intellectual Property
56:42 • 2min
25
Biotec - What's Next for Biotec?
58:56 • 2min
26
The Long Run, a Production Oftier and Report
01:00:54 • 2min